To test our hypothesis that kisspeptin has an anti-fibrotic effect in the human liver, we utilized hPCLS generated from stromal (fibrotic, non-tumor) biopsies from three male patients with HCC (Table 1). This evidence concerns the gene KISS1 and hepatocellular carcinoma.